TTG Imaging Solutions Awarded Integrated Oncology Network Purchasing Agreement for Equipment Service

The partnership solidifies TTGs collective breadth of knowledge and experience to deliver oncology service to a broad continuum of IONs health care partners.

Mon Dec 14 2020By TTG Imaging Solutions

PITTSBURGH, PA (December 14, 2020) – TTG Imaging Solutions, LLC (TTG), a national leader in diagnostic imaging solutions, and Integrated Oncology Network (ION), a nationwide leader in PET/CT imaging, oncology and urology programs, are proud to announce a 5-year service agreement. Effective April 1, 2021, the agreement awards TTG’s team of OEM certified Field Service Engineers to service the diverse portfolio of equipment at ION’s imaging and oncology centers nationwide. The partnership solidifies TTG’s collective breadth of knowledge and experience to deliver oncology service to a broad continuum of ION’s health care partners.

“The long-term contract with ION is a great opportunity for TTG to expand its service line and partner with such a renowned operator in the Oncology marketplace,” says Jack Tomayko, TTG President & CEO.

“We explored several options and determined that TTG was the ideal choice in providing quality service to our imaging equipment. Their capabilities and expertise align with ION’s needs to service the wide range of equipment across our geographical presence,” says Josh Johnson, ION CEO.

About Integrated Oncology Network (ION)

ION partners directly with hospitals, physicians and other health care providers to offer the latest PET/CT imaging, oncology and urology technologies to their patients. Founded in 2008, ION has grown to 48 centers in 16 states, providing a complete and integrated continuum of care – diagnostic testing, radiation oncology, medical oncology, urology and ancillary services. For more information, visit

About TTG Imaging Solutions, LLC (TTG)

TTG Imaging Solutions, LLC offers the best in diagnostic imaging equipment sales, nationwide service, parts, clinical staffing, and radiopharmaceuticals. The company is headquartered in Pittsburgh, PA and led by President & CEO, Jack Tomayko. For more information, visit

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Please review our Privacy Policy for more details.
I Agree